出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年11月
Digital Health Market – Global Forecast to 2028
デジタルヘルス市場 : 収益モデル (サブスクリプション、サービスごとの支払い、無料アプリ)、テクノロジー (ウェアラブル、モバイルヘルス、遠隔医療、RPM、LTC モニタリング、人口健康管理、DTx)、EHR、ヘルスケア分析、電子処方、地域別 – 2028年までの世界予測
Digital Health Market by Revenue Model (Subscription, Pay per service, Free apps), Technology (Wearables, mHealth, Telehealthcare, RPM, LTC monitoring, Population Health management, DTx), EHR, Healthcare Analytics, ePrescribing & Region – Global Forecast to 2028
| ページ数 | 250 |
| 図表数 | 228 |
| 種別 | 英文調査報告書 |
| 価格 |
Report Overview
The Digital Health Market is projected to reach USD 549.7 billion by 2028 from USD 180.2 billion in 2023, at a CAGR of 25.0% during the forecast period. Digital health adoption is influenced by a wide range of factors. One of the major factors driving the market growth includes technological advancements. Advances in healthcare technology, such as wearable devices, telehealth platforms, electronic health records (EHRs), and mobile apps, make it easier for individuals to monitor their health and interact with healthcare providers. Moreover, improvements in healthcare infrastructure in emerging countries has led to an increase in adoption of digital health technologies thereby facilitating the market growth. On the other hand, data integration and interoperability issue is key factor restraining the market growt at certain extent over the forecast period.
“Software segment is estimated to hold the major share in 2022 in the global digital health market”
On the basis of offering, the digital health market is bifurcated into software, hardware, application and services. The software segment expected to account for the largest market share of the global digital health market in 2022. The development of user-friendly and intuitive interfaces makes it easier for both healthcare providers and patients to navigate and use digital health software. Growing availability of highly efficient software has fostered the segmental growth.
“Telehealthcare technology segment accounted for the largest share of the global digital health market”
On the basis of technology, the digital health market is segmented into mhealth, telehealth, digital therapeutics, healthcare management systems technologies. The telehealthcare segment accounted for the largest share of the global market in 2022. Patients with chronic conditions can receive ongoing care, monitoring, and education through telehealth, improving their management and reducing hospital readmissions. Moreover, improving reimbursement scenario for telehealth technology has increased its demand thereby, positively impacting the segment growth.
“Providers segment expectd to hold the largest share of the market in 2022”
On the basis of end user, the digital health market is divided into providers, payers and consumers and patients segment. In 2022, the providers segment accounted for the largest share of the digital health market. Digital health technologies assist hospitals in managing their resources more effectively, such as managing hospital beds, equipment, and staff schedules. Moreover, hospitals use digital health technologies to provide more patient-centered care, catering to the preferences and needs of individual patients. Aforementioned factors have positively impacted the segment growth.
“North America to dominate the digital health market in 2022”
The global digital health market is segmented into four major regions, namely, North America, Europe, Asia Pacific, Latin America and MEA. In 2022, North America accounted for the largest and the fastest-growing regional market for digital health. Well-developed healthcare infrastructure along with high awareness for digital health technologies such a digital therapeutics and telehealth has facilitated the regional growth.
Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Supply Side: Tier 1 (31%), Tier 2 (28%), and Tier 3 (41%)
• By Demand Side: Purchase Managers (45%), Head Of AI, ML, Drud Discovery & Computational Molecular Design (30%), Research Scientists (25%)
• By Designation: C-level (31%), Director-level (25%), and Others (44%)
• By Region: North America (45%), Europe (20%), Asia Pacific (28%), and RoW (7%)
Prominent players in this market are Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE HealthCare (US), Abbott (US), OMRON Corporation (Japan), Fitbit, Inc. (A Google Company) (US), Johnson & Johnson Private Limited (US), Siemens Healthineers AG (Germany), Masimo (US), Apple, Inc. (US), Merative (US), AT &T, Inc. (US), Veradigm LLC (US), Noom, Inc. (US), Teladoc Health, Inc. (US), Omada Health Inc. (US), Dexcom, Inc. (US), Biotricity (US), iHealth Labs Inc (US), my mhealth Limited (UK), athenahealth (US), eClinicalWorks (US), AirStrip Technologies, Inc (US), AdvancedMD, Inc. (US) and Qardio, Inc. (US). Players adopted organic as well as inorganic growth strategies such as product upgrades, collaborations, agreements, partnerships, and acquisitions to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.
Research Coverage
• The report studies the digital health market based on offering, technology, application, end user, and region
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
• The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total AI in drug discovery market
• The report forecasts the revenue of market segments with respect to five major regions
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies.
This report provides insights into the following pointers:
• Analysis of key drivers (increasing penetration of mobile phones, supporting government initiatives and rising geriatric population and chronic diseases), restraints (privacy and security concerns, interoperability challenges), opportunities (intelligent digital health solutions for universal access, improving regulatory scenario, rising awareness and adoption trends in emerging countries), and challenges (healthcare gaps in emerging economeis) influencing the growth of digital health market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the digital health market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of digital health solutions across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the digital health market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the digital health market.
Table of Contents
1 INTRODUCTION 28
1.1 STUDY OBJECTIVES 28
1.2 MARKET DEFINITION 28
1.2.1 INCLUSIONS AND EXCLUSIONS OF STUDY 28
1.3 MARKET SCOPE 29
1.3.1 MARKET SEGMENTATION 29
1.3.2 REGIONAL SCOPE 29
1.3.3 YEARS CONSIDERED 30
1.4 CURRENCY 30
1.5 STAKEHOLDERS 30
1.6 RECESSION IMPACT 31
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH APPROACH 32
FIGURE 1 RESEARCH DESIGN 32
2.1.1 SECONDARY RESEARCH 32
2.1.1.1 Key data from secondary sources 33
2.1.2 PRIMARY DATA 34
FIGURE 2 PRIMARY SOURCES 34
2.1.2.1 Key data from primary interviews 35
2.1.2.2 Insights from primary experts 35
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 36
2.2 MARKET SIZE ESTIMATION 36
FIGURE 4 MARKET SIZE ESTIMATION: DIGITAL HEALTH MARKET 36
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 37
FIGURE 6 TOP-DOWN APPROACH 37
FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028) 38
FIGURE 8 DIGITAL HEALTH MARKET: CAGR PROJECTIONS 39
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 40
FIGURE 9 DATA TRIANGULATION METHODOLOGY 40
2.4 MARKET RANKING ANALYSIS 41
2.5 STUDY ASSUMPTIONS 41
2.6 LIMITATIONS 41
2.6.1 METHODOLOGY-RELATED LIMITATIONS 41
2.6.2 SCOPE-RELATED LIMITATIONS 41
2.7 RISK ASSESSMENT 42
TABLE 1 RISK ASSESSMENT ANALYSIS 42
2.8 RECESSION IMPACT ANALYSIS 42
3 EXECUTIVE SUMMARY 43
FIGURE 10 DIGITAL HEALTH MARKET, BY OFFERING, 2023 VS. 2028 (USD MILLION) 43
FIGURE 11 DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 44
FIGURE 12 DIGITAL HEALTH MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 45
FIGURE 13 DIGITAL HEALTH MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 45
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF DIGITAL HEALTH MARKET 46
4 PREMIUM INSIGHTS 48
4.1 DIGITAL HEALTH MARKET OVERVIEW 48
FIGURE 15 RISING FOCUS ON PATIENT-CENTRIC HEALTHCARE SOLUTIONS TO DRIVE MARKET 48
4.2 ASIA PACIFIC: DIGITAL HEALTH MARKET, BY TECHNOLOGY AND COUNTRY (2022) 49
FIGURE 16 TELEHEALTHCARE ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2022 49
4.3 DIGITAL HEALTH MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 50
FIGURE 17 MARKET IN CHINA TO REGISTER HIGHEST GROWTH 50
4.4 DIGITAL HEALTH MARKET: REGIONAL MIX 51
FIGURE 18 MIDDLE EAST & AFRICA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 51
4.5 DIGITAL HEALTH MARKET: DEVELOPED VS. EMERGING MARKETS 51
FIGURE 19 EMERGING MARKETS TO REGISTER HIGHER GROWTH BETWEEN 2023 & 2028 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
FIGURE 20 DIGITAL HEALTH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52
TABLE 2 MARKET DYNAMICS: IMPACT ANALYSIS 53
5.2.1 DRIVERS 53
5.2.1.1 Increasing penetration of smartphones, tablets, and other mobile platforms 53
FIGURE 21 SMARTPHONE USERS WORLDWIDE, 2016–2027 (BILLION) 54
5.2.1.2 Supportive initiatives and increasing strategic alliances 54
FIGURE 22 NUMBER OF PARTNERSHIPS WORLDWIDE, JANUARY–SEPTEMBER 2022 55
5.2.1.3 Rising geriatric population and subsequent increase in prevalence of chronic diseases 55
FIGURE 23 GERIATRIC POPULATION, BY REGION, 2010–2030 (% OF TOTAL POPULATION) 55
5.2.1.4 Rising focus on patient-centric healthcare solutions 56
5.2.2 RESTRAINTS 57
5.2.2.1 High cost of deployment of digital health solutions for small and medium-sized hospitals in emerging countries 57
5.2.2.2 Interoperability issues 58
5.2.3 OPPORTUNITIES 58
5.2.3.1 Shift toward intelligent health ecosystem to deliver personalized health experiences 58
5.2.3.2 Digital health solutions for universal healthcare access 59
5.2.3.3 Improving regulatory support and reimbursements 59
5.2.3.4 Advancements in digital health 59
5.2.4 CHALLENGES 60
5.2.4.1 Healthcare gap in emerging economies 60
5.2.4.2 Privacy and security concerns 60
FIGURE 24 HEALTHCARE BREACHES REPORTED TO US DEPARTMENT OF HEALTH AND HUMAN SERVICES IN 2021 61
5.3 INDUSTRY TRENDS 61
5.3.1 EMERGENCE OF VALUE-BASED STRATEGY FOR CONTINUOUS CARE 61
5.3.2 CONSUMER EMPOWERMENT 62
5.3.3 TECHNOLOGICALLY ENABLED PRIMARY CARE SERVICES 62
5.3.4 RISING AWARENESS OF DIGITAL THERAPEUTICS TO TREAT HUMAN DISEASES 63
5.3.5 PENETRATION OF PAID MEDICAL APPS 63
5.4 TECHNOLOGY ANALYSIS 63
5.4.1 HEALTHCARE ANALYTICS 63
5.4.2 CLOUD HEALTHCARE 64
5.4.3 PATIENT ENGAGEMENT 64
5.4.4 HOME HEALTHCARE 65
5.4.5 DIGITAL BIOMARKERS 65
5.5 PRICING ANALYSIS 65
5.5.1 AVERAGE SELLING PRICE OF MEDICAL DEVICES IN DIGITAL HEALTH MARKET 66
TABLE 3 REMOTE PATIENT MONITORING (RPM) BILLING AND REIMBURSEMENT CPT CODES 66
5.6 PORTER’S FIVE FORCES ANALYSIS 66
TABLE 4 DIGITAL HEALTH MARKET: PORTER’S FIVE FORCES ANALYSIS 66
5.6.1 INTENSITY OF COMPETITIVE RIVALRY 66
5.6.2 BARGAINING POWER OF SUPPLIERS 67
5.6.3 BARGAINING POWER OF BUYERS 67
5.6.4 THREAT OF NEW ENTRANTS 67
5.6.5 THREAT OF SUBSTITUTES 67
5.7 REGULATORY LANDSCAPE 67
5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
TABLE 8 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 9 DIGITAL HEALTH MARKET: REGULATORY STANDARDS 74
5.8 VALUE CHAIN ANALYSIS 75
FIGURE 25 DIGITAL HEALTH MARKET: VALUE CHAIN ANALYSIS 75
5.8.1 RESEARCH AND PRODUCT DEVELOPMENT 75
5.8.2 MATERIAL COMPONENTS 75
5.8.3 MANUFACTURERS AND DEVELOPERS 76
5.8.4 DISTRIBUTION AND SALES 76
5.8.5 END-USER INDUSTRIES 76
5.8.6 POST-SALE SERVICES 76
5.9 ECOSYSTEM/MARKET MAP 76
FIGURE 26 DIGITAL HEALTH MARKET: ECOSYSTEM 77
TABLE 10 DIGITAL HEALTH MARKET: ECOSYSTEM 77
5.10 REVENUE SHIFT AND NEW REVENUE POCKETS FOR DIGITAL HEALTH MARKET 78
FIGURE 27 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 78
5.11 CASE STUDY ANALYSIS 79
5.11.1 CASE STUDY 1: CLÍNICAS DEL AZÚCAR (CDA) 79
5.11.2 CASE STUDY 2: NOVA HOSPITAL & ENOVACOM 79
5.11.3 CASE STUDY 3: APPLE & NHS TEAMS 80
5.12 PATENT ANALYSIS 81
FIGURE 28 NUMBER OF PATENTS PUBLISHED, JANUARY 2013–OCTOBER 2023 81
FIGURE 29 TOP PATENT OWNERS IN DIGITAL HEALTH MARKET, JANUARY 2013–OCTOBER 2023 81
TABLE 11 KEY PATENTS IN DIGITAL HEALTH MARKET 82
5.13 ADJACENT MARKET ANALYSIS 83
FIGURE 30 POPULATION HEALTH MANAGEMENT MARKET OVERVIEW 83
FIGURE 31 METAVERSE IN HEALTHCARE MARKET OVERVIEW 84
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 84
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 84
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 84
TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 85
5.14.2 BUYING CRITERIA 85
FIGURE 33 KEY BUYING CRITERIA FOR DIGITAL HEALTH OFFERINGS 85
TABLE 13 KEY BUYING CRITERIA FOR DIGITAL MARKET OFFERINGS 85
5.15 KEY CONFERENCES AND EVENTS IN 2023–2024 86
TABLE 14 DIGITAL HEALTH MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 86
5.16 UNMET NEEDS IN DIGITAL HEALTH MARKET 86
TABLE 15 UNMET NEEDS IN DIGITAL HEALTH MARKET 86
5.16.1 END-USER EXPECTATIONS 87
TABLE 16 END-USER EXPECTATIONS IN DIGITAL HEALTH MARKET 87
6 DIGITAL HEALTH MARKET, BY OFFERING 89
6.1 INTRODUCTION 90
TABLE 17 DIGITAL HEALTH MARKET, BY OFFERING, 2021–2028 (USD MILLION) 90
6.2 HARDWARE 90
6.2.1 INCREASING DEMAND FOR DATA PROCESSING AND STORAGE TO DRIVE MARKET 90
TABLE 18 DIGITAL HEALTH HARDWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
6.3 SOFTWARE 91
TABLE 19 DIGITAL HEALTH SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION) 91
TABLE 20 DIGITAL HEALTH SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
6.3.1 ANNUAL LICENSING 93
6.3.1.1 Pricing model where users pay recurring fees on yearly basis 93
TABLE 21 ANNUAL LICENSING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
6.3.2 SUBSCRIPTION-BASED 94
6.3.2.1 Provides flexibility to scale usage as needed 94
TABLE 22 SUBSCRIPTION-BASED SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
6.4 SERVICES 94
TABLE 23 DIGITAL HEALTH SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 95
TABLE 24 DIGITAL HEALTH SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
6.4.1 SUBSCRIPTION-BASED 96
6.4.1.1 Offer ongoing access to healthcare solutions and support 96
TABLE 25 SUBSCRIPTION-BASED SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
6.4.2 PAY-PER-USE (VALUE-BASED) 97
6.4.2.1 Users pay for individual healthcare services 97
TABLE 26 PAY-PER-USE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 97
6.5 APPLICATIONS 98
TABLE 27 DIGITAL HEALTH APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 98
TABLE 28 DIGITAL HEALTH APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
6.5.1 ONE-TIME PURCHASE 99
6.5.1.1 Model popular for fitness trackers 99
TABLE 29 ONE-TIME PURCHASE APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99
6.5.2 SUBSCRIPTION-BASED 100
6.5.2.1 Require users to pay recurring fees 100
TABLE 30 SUBSCRIPTION-BASED APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 100
6.5.3 PAY-PER-USE (VALUE-BASED) 101
6.5.3.1 Allow users to pay for specific services 101
TABLE 31 PAY-PER-USE APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 101
7 DIGITAL HEALTH MARKET, BY TECHNOLOGY 102
7.1 INTRODUCTION 103
TABLE 32 DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 103
7.2 TELEHEALTHCARE 103
TABLE 33 TELEHEALTHCARE MARKET, BY TYPE, 2021–2028 (USD MILLION) 104
TABLE 34 TELEHEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 104
7.2.1 TELECARE/RPM 105
TABLE 35 TELECARE MARKET, BY TYPE, 2021–2028 (USD MILLION) 105
TABLE 36 TELECARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105
7.2.1.1 Activity monitoring 106
7.2.1.1.1 Plays crucial role in promoting fitness and wellness 106
TABLE 37 ACTIVITY MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 106
7.2.1.2 Remote medication management 107
7.2.1.2.1 Vital tool for patients and healthcare providers 107
TABLE 38 REMOTE MEDICATION MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
7.2.2 TELEHEALTH 108
TABLE 39 TELEHEALTH MARKET, BY TYPE, 2021–2028 (USD MILLION) 108
TABLE 40 TELEHEALTH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 108
7.2.2.1 LTC monitoring 109
7.2.2.1.1 Reducing need for frequent in-person visits 109
TABLE 41 LTC MONITORING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
7.2.2.2 Video consultation 110
7.2.2.2.1 Enables real-time remote medical consultations between healthcare providers and patients 110
TABLE 42 VIDEO CONSULTATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
7.3 MHEALTH 111
TABLE 43 MHEALTH MARKET, BY TYPE, 2021–2028 (USD MILLION) 111
TABLE 44 MHEALTH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
7.3.1 WEARABLES 112
TABLE 45 MHEALTH DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 112
TABLE 46 MHEALTH DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 113
7.3.1.1 Vital signs monitors 114
7.3.1.1.1 Need for continuous patient monitoring to drive adoption 114
TABLE 47 VITAL SIGNS MONITORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
7.3.1.2 Peak flow meters 115
7.3.1.2.1 Provide critical insights into lung function 115
TABLE 48 PEAK FLOW METERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
7.3.1.3 Fetal monitors 116
7.3.1.3.1 Provides data on heart rate, fetal movement, and fetal position 116
TABLE 49 FETAL MONITORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
7.3.1.4 Sleep apnea monitors 117
7.3.1.4.1 Provide real-time data to diagnose and manage sleep apnea 117
TABLE 50 SLEEP APNEA MONITORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
7.3.1.5 Neurological monitors 118
7.3.1.5.1 Enable real-time monitoring of neurological conditions and disorders 118
TABLE 51 NEUROLOGICAL MONITORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
7.3.1.6 Other wearables 119
TABLE 52 OTHER WEARABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
7.3.2 MHEALTH APPS 119
TABLE 53 MHEALTH APPS MARKET, BY TYPE, 2021–2028 (USD MILLION) 120
TABLE 54 MHEALTH APPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
7.3.2.1 Medical apps 121
7.3.2.1.1 Allow for streamlined communication and data sharing between all stakeholders 121
TABLE 55 MEDICAL APPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
7.3.2.2 Fitness apps 122
7.3.2.2.1 Empower users to lead healthier lifestyles 122
TABLE 56 FITNESS APPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
7.4 DIGITAL THERAPEUTICS 123
TABLE 57 DIGITAL THERAPEUTICS MARKET, BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 58 DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
7.4.1 PREVENTIVE APPLICATIONS 124
7.4.1.1 Rising awareness of self-health management to drive market 124
TABLE 59 PREVENTIVE APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
7.4.2 TREATMENT APPLICATIONS 125
7.4.2.1 Rising prevalence of chronic diseases to drive market 125
TABLE 60 TREATMENT APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
7.5 HEALTH MANAGEMENT SOLUTIONS 126
TABLE 61 HEALTH MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 126
TABLE 62 HEALTH MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
7.5.1 ELECTRONIC HEALTH RECORDS 127
7.5.1.1 Increased adoption of EHRs in emerging countries to drive market 127
TABLE 63 ELECTRONIC HEALTH RECORDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
7.5.2 HEALTHCARE ANALYTICS 128
7.5.2.1 Support for fact-based diagnostics and therapeutic decision-making to ensure demand 128
TABLE 64 HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128
7.5.3 EPRESCRIBING 129
7.5.3.1 Integrated ePrescribing solutions offer significant benefits over standalone systems 129
TABLE 65 EPRESCRIBING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
8 DIGITAL HEALTH MARKET, BY APPLICATION 130
8.1 INTRODUCTION 131
TABLE 66 DIGITAL HEALTH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 131
8.2 CHRONIC DISEASE MANAGEMENT 131
8.2.1 CHRONIC DISEASE MANAGEMENT SEGMENT TO DOMINATE DIGITAL HEALTH MARKET 131
TABLE 67 DIGITAL HEALTH MARKET FOR CHRONIC DISEASE MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION) 132
8.3 BEHAVIORAL HEALTH 132
8.3.1 RISING AWARENESS OF MENTAL HEALTH TO DRIVE GROWTH 132
TABLE 68 DIGITAL HEALTH MARKET FOR BEHAVIORAL HEALTH, BY COUNTRY, 2021–2028 (USD MILLION) 133
8.4 HEALTH & FITNESS 134
8.4.1 HEALTH & FITNESS SEGMENT TO WITNESS HIGH GROWTH DURING FORECAST PERIOD 134
TABLE 69 DIGITAL HEALTH MARKET FOR HEALTH & FITNESS, BY COUNTRY, 2021–2028 (USD MILLION) 134
8.5 OTHER APPLICATIONS 135
TABLE 70 DIGITAL HEALTH MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 135
9 DIGITAL HEALTH MARKET, BY END USER 136
9.1 INTRODUCTION 137
TABLE 71 DIGITAL HEALTH MARKET, BY END USER, 2021–2028 (USD MILLION) 137
9.2 PROVIDERS 137
TABLE 72 DIGITAL HEALTH MARKET FOR PROVIDERS, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 73 DIGITAL HEALTH MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION) 138
9.2.1 HOSPITALS & CLINICS 138
9.2.1.1 Need to reduce healthcare costs to drive market 138
TABLE 74 DIGITAL HEALTH MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 139
9.2.2 LONG-TERM CARE CENTERS & ASSISTED LIVING CENTERS 139
9.2.2.1 Increasing geriatric population to support market growth 139
TABLE 75 DIGITAL HEALTH MARKET FOR LONG-TERM CARE CENTERS & ASSISTED LIVING CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 140
9.3 PAYERS 140
TABLE 76 DIGITAL HEALTH MARKET FOR PAYERS, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 77 DIGITAL HEALTH MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 141
9.3.1 PUBLIC 142
9.3.1.1 Focus on developing outcome-based payment models to drive demand for digital health solutions 142
TABLE 78 DIGITAL HEALTH MARKET FOR PUBLIC PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 142
9.3.2 PRIVATE 143
9.3.2.1 Increase in operational efficiency to boost demand for digital health among private payers 143
TABLE 79 DIGITAL HEALTH MARKET FOR PRIVATE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 143
9.4 PATIENTS & CONSUMERS 144
9.4.1 INCREASING AWARENESS OF SELF-HEALTH MANAGEMENT TO DRIVE MARKET 144
TABLE 80 DIGITAL HEALTH MARKET FOR PATIENTS & CONSUMERS, BY COUNTRY, 2021–2028 (USD MILLION) 144
10 DIGITAL HEALTH MARKET, BY REGION 145
10.1 INTRODUCTION 146
TABLE 81 DIGITAL HEALTH MARKET, BY REGION, 2021–2028 (USD MILLION) 146
10.2 NORTH AMERICA 146
FIGURE 34 NORTH AMERICA: DIGITAL HEALTH MARKET SNAPSHOT 147
TABLE 82 NORTH AMERICA: DIGITAL HEALTH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 83 NORTH AMERICA: DIGITAL HEALTH MARKET, BY OFFERING, 2021–2028 (USD MILLION) 148
TABLE 84 NORTH AMERICA: DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 148
TABLE 85 NORTH AMERICA: DIGITAL HEALTH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 149
TABLE 86 NORTH AMERICA: DIGITAL HEALTH MARKET, BY END USER, 2021–2028 (USD MILLION) 149
10.2.1 US 149
10.2.1.1 High adoption rate of connected medical devices to drive market 149
TABLE 87 US: DIGITAL HEALTH MARKET, BY OFFERING, 2021–2028 (USD MILLION) 150
TABLE 88 US: DIGITAL HEALTH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 150
TABLE 89 US: DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 151
TABLE 90 US: DIGITAL HEALTH MARKET, BY END USER, 2021–2028 (USD MILLION) 151
10.2.2 CANADA 151
10.2.2.1 Federal investments in health-related technologies to boost market 151
TABLE 91 CANADA: DIGITAL HEALTH MARKET, BY OFFERING, 2021–2028 (USD MILLION) 152
TABLE 92 CANADA: DIGITAL HEALTH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 152
TABLE 93 CANADA: DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 153
TABLE 94 CANADA: DIGITAL HEALTH MARKET, BY END USER, 2021–2028 (USD MILLION) 153
10.3 EUROPE 153
TABLE 95 EUROPE: DIGITAL HEALTH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 96 EUROPE: DIGITAL HEALTH MARKET, BY OFFERING, 2021–2028 (USD MILLION) 154
TABLE 97 EUROPE: DIGITAL HEALTH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 155
TABLE 98 EUROPE: DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 155
TABLE 99 EUROPE: DIGITAL HEALTH MARKET, BY END USER, 2021–2028 (USD MILLION) 155
10.3.1 GERMANY 156
10.3.1.1 Government initiatives to support market growth 156
TABLE 100 GERMANY: DIGITAL HEALTH MARKET, BY OFFERING, 2021–2028 (USD MILLION) 156
TABLE 101 GERMANY: DIGITAL HEALTH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 157
TABLE 102 GERMANY: DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 157
TABLE 103 GERMANY: DIGITAL HEALTH MARKET, BY END USER, 2021–2028 (USD MILLION) 157
10.3.2 UK 158
10.3.2.1 High penetration of wearables to drive market 158
TABLE 104 UK: DIGITAL HEALTH MARKET, BY OFFERING, 2021–2028 (USD MILLION) 158
TABLE 105 UK: DIGITAL HEALTH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 159
TABLE 106 UK: DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 159
TABLE 107 UK: DIGITAL HEALTH MARKET, BY END USER, 2021–2028 (USD MILLION) 159
10.3.3 FRANCE 160
10.3.3.1 Government support for e-Health to propel market 160
TABLE 108 FRANCE: DIGITAL HEALTH MARKET, BY OFFERING, 2021–2028 (USD MILLION) 160
TABLE 109 FRANCE: DIGITAL HEALTH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 161
TABLE 110 FRANCE: DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 161
TABLE 111 FRANCE: DIGITAL HEALTH MARKET, BY END USER, 2021–2028 (USD MILLION) 161
10.3.4 REST OF EUROPE 162
TABLE 112 REST OF EUROPE: DIGITAL HEALTH MARKET, BY OFFERING, 2021–2028 (USD MILLION) 162
TABLE 113 REST OF EUROPE: DIGITAL HEALTH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 163
TABLE 114 REST OF EUROPE: DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 163
TABLE 115 REST OF EUROPE: DIGITAL HEALTH MARKET, BY END USER, 2021–2028 (USD MILLION) 164
10.4 ASIA PACIFIC 164
FIGURE 35 ASIA PACIFIC: DIGITAL HEALTH MARKET SNAPSHOT 165
TABLE 116 ASIA PACIFIC: DIGITAL HEALTH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 117 ASIA PACIFIC: DIGITAL HEALTH MARKET, BY OFFERING, 2021–2028 (USD MILLION) 166
TABLE 118 ASIA PACIFIC: DIGITAL HEALTH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 166
TABLE 119 ASIA PACIFIC: DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 167
TABLE 120 ASIA PACIFIC: DIGITAL HEALTH MARKET, BY END USER, 2021–2028 (USD MILLION) 167
10.4.1 CHINA 167
10.4.1.1 High burden of chronic diseases to support market growth 167
TABLE 121 CHINA: DIGITAL HEALTH MARKET, BY OFFERING, 2021–2028 (USD MILLION) 168
TABLE 122 CHINA: DIGITAL HEALTH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 168
TABLE 123 CHINA: DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 169
TABLE 124 CHINA: DIGITAL HEALTH MARKET, BY END USER, 2021–2028 (USD MILLION) 169
10.4.2 JAPAN 169
10.4.2.1 Large geriatric population to propel market 169
TABLE 125 JAPAN: DIGITAL HEALTH MARKET, BY OFFERING, 2021–2028 (USD MILLION) 170
TABLE 126 JAPAN: DIGITAL HEALTH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 171
TABLE 127 JAPAN: DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 171
TABLE 128 JAPAN: DIGITAL HEALTH MARKET, BY END USER, 2021–2028 (USD MILLION) 171
10.4.3 INDIA 172
10.4.3.1 Growing adoption of telemedicine to drive market 172
TABLE 129 INDIA: DIGITAL HEALTH MARKET, BY OFFERING, 2021–2028 (USD MILLION) 172
TABLE 130 INDIA: DIGITAL HEALTH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 173
TABLE 131 INDIA: DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 173
TABLE 132 INDIA: DIGITAL HEALTH MARKET, BY END USER, 2021–2028 (USD MILLION) 173
10.4.4 REST OF ASIA PACIFIC 174
TABLE 133 REST OF ASIA PACIFIC: DIGITAL HEALTH MARKET, BY OFFERING, 2021–2028 (USD MILLION) 174
TABLE 134 REST OF ASIA PACIFIC: DIGITAL HEALTH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 175
TABLE 135 REST OF ASIA PACIFIC: DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 175
TABLE 136 REST OF ASIA PACIFIC: DIGITAL HEALTH MARKET, BY END USER, 2021–2028 (USD MILLION) 176
10.5 LATIN AMERICA 176
10.5.1 GOVERNMENT SUPPORT FOR ADOPTION OF CONNECTED MEDICAL DEVICES TO PROPEL MARKET 176
TABLE 137 LATIN AMERICA: DIGITAL HEALTH MARKET, BY OFFERING, 2021–2028 (USD MILLION) 176
TABLE 138 LATIN AMERICA: DIGITAL HEALTH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 177
TABLE 139 LATIN AMERICA: DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 177
TABLE 140 LATIN AMERICA: DIGITAL HEALTH MARKET, BY END USER, 2021–2028 (USD MILLION) 177
10.6 MIDDLE EAST & AFRICA 178
10.6.1 INCREASING DEMAND FOR QUALITY HEALTHCARE TO DRIVE MARKET 178
TABLE 141 MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET, BY OFFERING, 2021–2028 (USD MILLION) 178
TABLE 142 MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 179
TABLE 143 MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 179
TABLE 144 MIDDLE EAST & AFRICA: DIGITAL HEALTH MARKET, BY END USER, 2021–2028 (USD MILLION) 180
11 COMPETITIVE LANDSCAPE 181
11.1 INTRODUCTION 181
11.2 STRATEGIES ADOPTED BY KEY PLAYERS 181
FIGURE 36 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2020 AND SEPTEMBER 2023 182
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 182
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN DIGITAL HEALTH MARKET, 2018–2022 (USD BILLION) 183
11.4 MARKET RANKING ANALYSIS 183
FIGURE 38 DIGITAL HEALTH MARKET RANKING ANALYSIS OF KEY PLAYERS (2022) 184
11.5 COMPANY EVALUATION MATRIX 185
11.5.1 STARS 185
11.5.2 EMERGING LEADERS 185
11.5.3 PERVASIVE PLAYERS 185
11.5.4 PARTICIPANTS 185
FIGURE 39 DIGITAL HEALTH MARKET: COMPANY EVALUATION MATRIX, 2022 186
11.6 COMPANY FOOTPRINT 187
TABLE 145 COMPANY FOOTPRINT 187
TABLE 146 OFFERING FOOTPRINT 187
TABLE 147 TECHNOLOGY FOOTPRINT 188
TABLE 148 REGION FOOTPRINT 189
11.7 STARTUP/SME EVALUATION MATRIX 190
11.7.1 PROGRESSIVE COMPANIES 190
11.7.2 DYNAMIC COMPANIES 190
11.7.3 RESPONSIVE COMPANIES 190
11.7.4 STARTING BLOCKS 190
FIGURE 40 DIGITAL HEALTH MARKET: STARTUP/SME EVALUATION MATRIX, 2022 191
11.7.5 COMPETITIVE BENCHMARKING 191
TABLE 149 STARTUP/SME FOOTPRINT ANALYSIS 191
TABLE 150 OFFERING FOOTPRINT 192
TABLE 151 TECHNOLOGY FOOTPRINT 192
TABLE 152 REGION FOOTPRINT 192
11.8 COMPETITIVE SCENARIO AND TRENDS 193
11.8.1 PRODUCT LAUNCHES 193
TABLE 153 DIGITAL HEALTH MARKET: PRODUCT LAUNCHES, 2020–2023 193
11.8.2 DEALS 193
TABLE 154 DIGITAL HEALTH MARKET: DEALS, 2020–2023 193
11.8.3 OTHER DEVELOPMENTS 194
TABLE 155 DIGITAL HEALTH MARKET: OTHER DEVELOPMENTS, 2020–2023 194
12 COMPANY PROFILES 195
12.1 KEYPLAYERS 195
(Business overview, Products & services offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and Competitive threats)*
12.1.1 KONINKLIJKE PHILIPS N.V. 195
TABLE 156 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 195
FIGURE 41 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022) 196
12.1.2 MEDTRONIC 199
TABLE 157 MEDTRONIC: BUSINESS OVERVIEW 199
FIGURE 42 MEDTRONIC: COMPANY SNAPSHOT (2022) 200
12.1.3 GE HEALTHCARE 204
TABLE 158 GE HEALTHCARE: BUSINESS OVERVIEW 204
FIGURE 43 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 204
12.1.4 ABBOTT 207
TABLE 159 ABBOTT: BUSINESS OVERVIEW 207
FIGURE 44 ABBOTT: COMPANY SNAPSHOT (2022) 208
12.1.5 OMRON CORPORATION 210
TABLE 160 OMRON CORPORATION: BUSINESS OVERVIEW 210
FIGURE 45 OMRON CORPORATION: COMPANY SNAPSHOT (2022) 211
12.1.6 FITBIT, INC. 214
TABLE 161 GOOGLE: BUSINESS OVERVIEW 214
FIGURE 46 GOOGLE: COMPANY SNAPSHOT (2022) 215
12.1.7 JOHNSON & JOHNSON PRIVATE LIMITED 217
TABLE 162 JOHNSON & JOHNSON PRIVATE LIMITED: BUSINESS OVERVIEW 217
FIGURE 47 JOHNSON & JOHNSON PRIVATE LIMITED: COMPANY SNAPSHOT (2022) 218
12.1.8 SIEMENS HEALTHINEERS AG 219
TABLE 163 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW 219
FIGURE 48 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2022) 219
12.1.9 MASIMO 221
TABLE 164 MASIMO: BUSINESS OVERVIEW 221
FIGURE 49 MASIMO: COMPANY SNAPSHOT (2022) 222
12.1.10 APPLE, INC. 224
TABLE 165 APPLE, INC.: BUSINESS OVERVIEW 224
FIGURE 50 APPLE, INC.: COMPANY SNAPSHOT (2022) 225
12.1.11 MERATIVE 227
TABLE 166 MERATIVE: COMPANY OVERVIEW 227
12.1.12 AT&T, INC. 228
TABLE 167 AT&T, INC.: BUSINESS OVERVIEW 228
FIGURE 51 AT&T, INC.: COMPANY SNAPSHOT (2022) 229
12.1.13 VERADIGM LLC 231
TABLE 168 VERADIGM LLC: BUSINESS OVERVIEW 231
FIGURE 52 VERADIGM LLC: COMPANY SNAPSHOT (2021) 231
12.1.14 NOOM, INC. 234
TABLE 169 NOOM, INC.: BUSINESS OVERVIEW 234
12.1.15 TELADOC HEALTH, INC. 236
TABLE 170 TELADOC HEALTH, INC.: BUSINESS OVERVIEW 236
FIGURE 53 TELADOC HEALTH, INC.: COMPANY SNAPSHOT (2022) 236
12.1.16 OMADA HEALTH INC. 239
TABLE 171 OMADA HEALTH INC.: BUSINESS OVERVIEW 239
12.1.17 DEXCOM, INC. 241
TABLE 172 DEXCOM, INC.: BUSINESS OVERVIEW 241
FIGURE 54 DEXCOM, INC.: COMPANY SNAPSHOT (2022) 241
12.1.18 BIOTRICITY 243
TABLE 173 BIOTRICITY: BUSINESS OVERVIEW 243
FIGURE 55 BIOTRICITY: COMPANY SNAPSHOT (2022) 243
12.2 OTHER PLAYERS 245
12.2.1 IHEALTH LABS INC. 245
12.2.2 MY MHEALTH LIMITED 246
12.2.3 ATHENAHEALTH, INC. 246
12.2.4 ECLINICALWORKS 247
12.2.5 AIRSTRIP TECHNOLOGIES, INC. 247
12.2.6 ADVANCEDMD, INC. 248
12.2.7 QARDIO, INC. 248
*Details on Business overview, Products & services offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and Competitive threats might not be captured in case of unlisted companies.
13 APPENDIX 249
13.1 DISCUSSION GUIDE 249
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 253
13.3 CUSTOMIZATION OPTIONS 255
13.4 RELATED REPORTS 255
13.5 AUTHOR DETAILS 256